X
Anfarm Hellas S.A. - Main Section
Anfarm Hellas S.A. - Main Component
Active Substance |
Strength |
Form |
Apixaban |
2.5mg/tab & 5mg/tab |
F.C.Tabs |
Brivaracetam |
10mg/ml |
Sol.Inf |
Brivaracetam |
10mg/ml |
Oral Solution |
Ceftaroline Fosamil |
600mg/vial |
Pd.C.So.In |
Ceftazidime/ Avibactam |
2 g/0.5 g |
Pd.C.So.In |
Dalbavancin |
500mg/vial |
Pd.C.So.In |
Isavuconazole |
200mg |
Pd.C.So.In |
Letermovir |
240mg & 480 mg |
C.So.In |
Letermovir |
240mg & 480 mg/tabs |
F.C. tabs |
Posaconazole |
40 mg/mL |
Oral Suspension |
Posaconazole |
100mg/tab |
G.R. tabs |
Posaconazole |
18 mg/mL |
C.So.In |
Remifentanil |
1, 2 and 5 mg/vial |
Pd.C.So.In |
Tedizolid phosphate |
200mg/tab |
F.C. Tabs |
Tedizolid phosphate |
200 mg |
Pd.C.So.In |
Teicoplanin |
200 mg & 400 mg/vial |
Pd.Sol.Inf |
Zoledronic acid |
4 mg/5 mL |
C.So.In |
Active Substance |
Strength |
Form |
Apixaban |
2.5mg/tab & 5mg/tab |
F.C.Tabs |
Brivaracetam |
10mg/ml |
Sol.Inf |
Brivaracetam |
10mg/ml |
Oral Solution |
Ceftaroline Fosamil |
600mg/vial |
Pd.C.So.In |
Ceftazidime/ Avibactam |
2 g/0.5 g |
Pd.C.So.In |
Dalbavancin |
500mg/vial |
Pd.C.So.In |
Isavuconazole |
200mg |
Pd.C.So.In |
Letermovir |
240mg & 480 mg |
C.So.In |
Letermovir |
240mg & 480 mg/tabs |
F.C. tabs |
Posaconazole |
40 mg/mL |
Oral Suspension |
Posaconazole |
100mg/tab |
G.R. tabs |
Posaconazole |
18 mg/mL |
C.So.In |
Remifentanil |
1, 2 and 5 mg/vial |
Pd.C.So.In |
Tedizolid phosphate |
200mg/tab |
F.C. Tabs |
Tedizolid phosphate |
200 mg |
Pd.C.So.In |
Teicoplanin |
200 mg & 400 mg/vial |
Pd.Sol.Inf |
Zoledronic acid |
4 mg/5 mL |
C.So.In |
Active Substance |
Strength |
Form |
Dossier Availability |
Apixaban |
2.5mg/tab & 5mg/tab |
F.C.Tabs |
Q4 2023 |
Brivaracetam |
10mg/ml |
Sol.Inf |
Q1 2023 |
Brivaracetam |
10mg/ml |
Oral Solution |
Q2 2023 |
Ceftaroline Fosamil |
600mg/vial |
Pd.C.So.In |
Q3 2024 |
Ceftazidime/ Avibactam |
2 g/0.5 g |
Pd.C.So.In |
on going |
Dalbavancin |
500mg/vial |
Pd.C.So.In |
Q4 2023 |
Isavuconazole |
200mg |
Pd.C.So.In |
Q1 / Q3 2024 |
Letermovir |
240mg & 480 mg |
C.So.In |
on going |
Letermovir |
240mg & 480 mg/tabs |
F.C. tabs |
on going |
Posaconazole |
40 mg/mL |
Oral Suspension |
on going |
Posaconazole |
100mg/tab |
G.R. tabs |
on going |
Posaconazole |
18 mg/mL |
C.So.In |
on going |
Remifentanil |
1, 2 and 5 mg/vial |
Pd.C.So.In |
Q3 2024 |
Tedizolid phosphate |
200mg/tab |
F.C. Tabs |
on going |
Tedizolid phosphate |
200 mg |
Pd.C.So.In |
on going |
Teicoplanin |
200 mg & 400 mg/vial |
Pd.Sol.Inf |
Q1 2023 |
Zoledronic acid |
4 mg/5 mL |
C.So.In |
on going |